April Kim

April Kim

Auto-generated profile, based on publicly available information

April Kim

Broad Institute of MIT and Harvard, Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2017 in Genome Medicine
Verified
Journal Article
Open access
PDF file
HNHoang T. Nguyen
Hoang T. Nguyen
JBJulien Bryois
Julien Bryois
AKApril Kim
April Kim
ADAmanda Dobbyn
Amanda Dobbyn
LHLaura M. Huckins
Laura M. Huckins
ESEli A. Stahl
Eli A. Stahl
Integrating rare variation from trio family and case–control studies has successfully implicated specific genes contributing to risk of neurodevelopmental disorders (NDDs) including autism spectrum disorders (ASD), intellectual disability (ID), developmental disorders (DDs), and epilepsy (EPI). For schizophrenia (SCZ), however, while sets of genes have been implicated through the study of rare variation, only two risk genes have been identified. We used hierarchical Bayesian modeling of rare-variant genetic architecture to estimate mean effect sizes and risk-gene proportions, analyzing the largest available collection of whole exome sequence data for SCZ (1,077 trios, 6,699 cases, and 13,028 controls), and data for four NDDs (ASD, ID, DD, and EPI; total 10,792 trios, and 4,058 cases and controls). For SCZ, we estimate there are 1,551 risk genes. There are more risk genes and they have weaker effects than for NDDs. We provide power analyses to predict the number of risk-gene discoveries as more data become available. We confirm and augment prior risk gene and gene set enrichment results for SCZ and NDDs. In particular, we detected 98 new DD risk genes at FDR < 0.05. Correlations of risk-gene posterior probabilities are high across four NDDs (ρ>0.55), but low between SCZ and the NDDs (ρ<0.3). An in-depth analysis of 288 NDD genes shows there is highly significant protein–protein interaction (PPI) network connectivity, and functionally distinct PPI subnetworks based on pathway enrichment, single-cell RNA-seq cell types, and multi-region developmental brain RNA-seq. We have extended a pipeline used in ASD studies and applied it to infer rare genetic parameters for SCZ and four NDDs ( https://github.com/hoangtn/extTADA ). We find many new DD risk genes, supported by gene set enrichment and PPI network connectivity analyses. We find greater similarity among NDDs than between NDDs and SCZ. NDD gene subnetworks are implicated in postnatally expressed presynaptic and postsynaptic genes, and for transcriptional and post-transcriptional gene regulation in prenatal neural progenitor and stem cells.

18 June 2024 in Nature Reviews Bioengineering
Verified
Journal Article
Closed access
PDF file
JNJutaek Nam
Jutaek Nam
AKApril Kim
April Kim
KKKidong Kim
Kidong Kim
JMJeong Hyun Moon
Jeong Hyun Moon
JBJuwon Baig
Juwon Baig
SSSejin Son
Sejin Son

16 August 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ABAlexander Benet
Alexander Benet
THTroy Halseth
Troy Halseth
JKJukyung Kang
Jukyung Kang
AKApril Kim
April Kim
RARose Ackermann
Rose Ackermann
ASAnna Schwendeman
Anna Schwendeman
Exenatide, a glucagon-like peptide-1 receptor agonist, is the active pharmaceutical ingredient in Byetta® and Bydureon®, two type 2 diabetes drug products that have generics and multiple follow-up formulations currently in development. Even though exenatide is known to be chemically and physically unstable at pH 7.5, there lacks a systematic evaluation of the impact of pH and excipients on the peptide solution stability. In this study, we established analytical methods to measure the chemical and physical degradation of the peptide in solution. Exenatide remained relatively stable at pH 4.5 when incubated at 37 °C. At pH 5.5–6.5, degradation was driven by oxidation, while driven by deamidation at pH 7.5–8.5. Significant aggregation of exenatide at pH 7.5 and 8.5 was detected by size exclusion chromatography and dynamic light scattering. Each pH value greater than 4.5 exhibited unique profiles corresponding to a loss of α-helical content and an increase in unordered structures. The addition of sugars, including mannitol, sorbitol and sucrose, conferred small protective effects against peptide aggregation when incubating at pH 7.5 and 37 °C, as measured by size-exclusion chromatography and dynamic light scattering. The results of this study will be useful for investigators developing generic exenatide products, peptide analogs and novel exenatide drug delivery systems.

9 June 2023 in Applied Materials Today
Verified
Journal Article
Closed access
YJYeonwoo Jang
Yeonwoo Jang
AKApril Kim
April Kim
JMJames Moon
James Moon
JLJae Young Lee
Jae Young Lee
HPHansoo Park
Hansoo Park

19 April 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
TLTaibo Li
Taibo Li
AKApril Kim
April Kim
JRJoseph Rosenbluh
Joseph Rosenbluh
HHHeiko Horn
Heiko Horn
LGLiraz Greenfeld
Liraz Greenfeld
KLKasper Lage
Kasper Lage
Functional genomics networks are widely used to identify unexpected pathway relationships in large genomic datasets. However, it is challenging to quantitatively compare the signal-to-noise ratio of different networks, the biology they describe, and to identify the optimal network to interpret a particular genetic dataset. Via GeNets users can train a machine-learning model (Quack) to make such comparisons; and they can execute, store, and share analyses of genetic and RNA sequencing datasets.

5 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
GPGreta Pintacuda
Greta Pintacuda
FLFrederik H. Lassen
Frederik H. Lassen
YHYu-Han H. Hsu
Yu-Han H. Hsu
AKApril Kim
April Kim
JMJacqueline M. Martín
Jacqueline M. Martín
KLKasper Lage
Kasper Lage
Combining genetic and cell-type-specific proteomic datasets can lead to new biological insights and therapeutic hypotheses, but a technical and statistical framework for such analyses is lacking. Here, we present an open-source computational tool called Genoppi that enables robust, standardized, and intuitive integration of quantitative proteomic results with genetic data. We used Genoppi to analyze sixteen cell-type-specific protein interaction datasets of four proteins (TDP-43, MDM2, PTEN, and BCL2) involved in cancer and neurological disease. Through systematic quality control of the data and integration with published protein interactions, we show a general pattern of both cell-type-independent and cell-type-specific interactions across three cancer and one human iPSC-derived neuronal type. Furthermore, through the integration of proteomic and genetic datasets in Genoppi, our results suggest that the neuron-specific interactions of these proteins are mediating their genetic involvement in neurodevelopmental and neurodegenerative diseases. Importantly, our analyses indicate that human iPSC-derived neurons are a relevant model system for studying the involvement of TDP-43 and BCL2 in amyotrophic lateral sclerosis.